In a study published recently in the journal Clinical Cancer Research, researchers at Baylor College of Medicine found that treating patients who have resectable malignant pleural mesothelioma, ...

Immunotherapy before surgery improved survival and tumor response rates in pleural mesothelioma patients, potentially reducing recurrence risk. The phase 2 trial involved Imfinzi alone or combined ...

A new survey from The Mesothelioma Center at Asbestos.com highlights growing selectivity in surgical recommendations while keeping surgery on the table for certain pleural mesothelioma patients.

Results from an early phase clinical trial presented this week at the World Conference on Lung Cancer Meeting in Barcelona, Spain, and published in the Nature Medicine journal today [Monday, 8 th ...

If you are newly diagnosed with mesothelioma, it is important that you learn all you can about the disease and your treatment options. In general, how your mesothelioma is treated will depend on the ...

Mesothelioma is a highly fatal disease with a survival rate of under 10% at five years. New advances with immunotherapy have improved survival, but only 23% of patients are alive at three years when ...

Please provide your email address to receive an email when new articles are posted on . Healio spoke with Melina Elpi Marmarelis, MD, about key takeaways from the MARS 2 trial presented at the ...

NORTH PHILADELPHIA (WPVI) -- Mesothelioma is one of the hardest cancers to treat, but from surgical techniques to drug combinations, progress is slowly being made, giving patients more time and ...

NORTH PHILADELPHIA (WPVI) -- You've probably heard of mesothelioma from commercials by law firms representing patients. However, few people really know what it is. It's a very difficult cancer, but ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a ...

Sugarbaker et al 1 are to be congratulated for their comprehensive review of the management of malignant peritoneal mesothelioma using cytoreductive surgery (CRS) and perioperative chemotherapy. Their ...

Treatment with high doses of radiotherapy may significantly boost survival for patients with mesothelioma, according to new findings. New results from a randomized clinical trial show that patients ...